Parkside Financial Bank & Trust’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164 Sell
5
-17
-77% -$612 ﹤0.01% 2672
2026
Q1
$779 Buy
+22
New +$895 ﹤0.01% 2433
2025
Q4
– Sell
-18
Closed -$848 – 2711
2025
Q3
$848 Sell
18
-14
-44% -$726 ﹤0.01% 2354
2025
Q2
$1.67K Sell
32
-31
-49% -$1.7K ﹤0.01% 2063
2025
Q1
$3.81K Buy
63
+55
+688% +$3.54K ﹤0.01% 1716
2024
Q4
$548 Buy
8
+3
+60% +$209 ﹤0.01% 1857
2024
Q3
$360 Buy
5
+3
+150% +$212 ﹤0.01% 1894
2024
Q2
$139 Sell
2
-23
-92% -$1.68K ﹤0.01% 1990
2024
Q1
$2K Buy
25
+19
+317% +$1.69K ﹤0.01% 1515
2023
Q4
$658 Sell
6
-72
-92% -$7.45K ﹤0.01% 1699
2023
Q3
$7.87K Hold
78
– – ﹤0.01% 1199
2023
Q2
$10.6K Hold
78
– – ﹤0.01% 1097
2023
Q1
$8.1K Buy
78
+1
+1% +$97 ﹤0.01% 1176
2022
Q4
$6.83K Sell
77
-20
-21% -$1.66K ﹤0.01% 1197
2022
Q3
$8K Sell
97
-91
-48% -$8.58K ﹤0.01% 1047
2022
Q2
$18K Sell
188
-6
-3% -$720 0.01% 832
2022
Q1
$29K Hold
194
– – 0.01% 719
2021
Q4
$28K Buy
194
+103
+113% +$14.6K 0.01% 702
2021
Q3
$12K Buy
91
+1
+1% +$131 ﹤0.01% 903
2021
Q2
$12K Buy
90
+7
+8% +$958 ﹤0.01% 906
2021
Q1
$11K Hold
83
– – ﹤0.01% 896
2020
Q4
$9K Buy
83
+47
+131% +$4.45K ﹤0.01% 899
2020
Q3
$3K Buy
36
+20
+125% +$1.63K ﹤0.01% 1033
2020
Q2
$1K Buy
16
+5
+45% +$348 ﹤0.01% 1291
2020
Q1
$1K Sell
11
-14
-56% -$1.29K ﹤0.01% 1228
2019
Q4
$3K Hold
25
– – ﹤0.01% 1040
2019
Q3
$2K Buy
25
+14
+127% +$1.31K ﹤0.01% 1130
2019
Q2
$1K Hold
11
– – ﹤0.01% 1334
2019
Q1
$1K Sell
11
-13
-54% -$945 ﹤0.01% 1298
2018
Q4
$2K Hold
24
– – ﹤0.01% 1039
2018
Q3
$2K Hold
24
– – ﹤0.01% 1056
2018
Q2
$2K Hold
24
– – ﹤0.01% 1036
2018
Q1
$2K Buy
24
+11
+85% +$657 ﹤0.01% 994
2017
Q4
$1K Hold
13
– – ﹤0.01% 1096
2017
Q3
$1K Buy
13
+6
+86% +$301 ﹤0.01% 1090
2017
Q2
$0 Buy
+7
New +$346 ﹤0.01% 1427
2017
Q1
– Sell
-15
Closed -$1K – 1379
2016
Q4
$1K Buy
+15
New +$637 ﹤0.01% 1064

Other funds holding CNMD

Parkside Financial Bank & Trust's CNMD Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its CONMED (CNMD) stake by 77% in Q2 2026, selling an estimated $612 and leaving 5 shares worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #2672.

Parkside Financial Bank & Trust first reported a position in CNMD in Q4 2016 and has held it in 37 quarters since. The position peaked at $29K in Q1 2022. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Parkside Financial Bank & Trust held 5 shares of CONMED worth $164 as of Q2 2026.
  • Parkside Financial Bank & Trust sold 17 CONMED shares in Q2 2026, an estimated $612.
  • CONMED made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2672 holding.
  • Parkside Financial Bank & Trust first reported a position in CONMED in Q4 2016 and has held it in 37 quarters since.
  • Parkside Financial Bank & Trust's CONMED position peaked at $29K in Q1 2022.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.